Drugs / CreaVax-PC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01171729 | Jul 2006 → May 2010 | prostate cancer | Samsung Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CreaVax-PC | “If patients decide to participate and are eligible, they will be enrolled in the study and will receive active product (CreaVax-PC).” NCT01171729 ↗ |
| Modality | Cell therapy | “Autologous dendritic cells pulsed with prostate cancer antigen and KLH” NCT01171729 ↗ |
| Route | Other | “CreaVax-PC injection” NCT01171729 ↗ |